Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $550.7M | $745.4M | $766.6M | $750.3M | $792.3M | $796.9M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$275.7M | $13.4M | $1.7M | -$27.0M | $65.8M | $87.5M |
| Net income | -$293.6M | -$25.3M | -$32.8M | -$8.9M | $16.4M | $30.4M |
| Diluted EPS | -$1.07 | -$0.06 | -$0.08 | -$0.02 | $0.04 | $0.09 |
| Operating cash flow | $131.3M | $178.8M | $146.8M | $138.3M | $183.9M | $167.9M |
| Free cash flow | $110.8M | $174.2M | $142.8M | $137.2M | $182.7M | $164.4M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -50.1% | 1.8% | 0.2% | -3.6% | 8.3% | 11.0% |
| Net margin | -53.3% | -3.4% | -4.3% | -1.2% | 2.1% | 3.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $200.6M | $195.3M | $198.6M | $203.0M | $203.1M | $196.0M | $194.8M | $194.0M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $19.9M | $20.4M | $18.2M | $23.4M | $26.8M | $14.6M | $22.7M | $14.0M |
| Net income | $6.7M | $4.0M | $6.8M | $11.1M | $12.8M | $1.1M | $5.4M | $1.2M |
| Diluted EPS | $0.02 | $0.01 | $0.01 | $0.03 | $0.04 | $0.00 | $0.02 | $0.00 |
| Operating cash flow | $9.7M | $86.9M | $44.7M | $9.4M | $49.6M | $76.0M | $32.9M | $11.8M |
| Free cash flow | $9.4M | $86.5M | $44.6M | $9.3M | $49.2M | $74.3M | $31.6M | $10.7M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 9.9% | 10.5% | 9.2% | 11.5% | 13.2% | 7.5% | 11.6% | 7.2% |
| Net margin | 3.3% | 2.0% | 3.4% | 5.4% | 6.3% | 0.6% | 2.8% | 0.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Barnes Wendy Lynn· See Remarks | Tax withholding | 50,021 | $3.01 | $150,563.21 | filing |
| 2026-07-15 | Barnes Wendy Lynn· See Remarks | Tax withholding | 48,203 | $3.01 | $145,091.03 | filing |
| 2026-07-15 | Barnes Wendy Lynn· See Remarks | Tax withholding | 22,232 | $3.01 | $66,918.32 | filing |
| 2026-07-15 | McGinnis Christopher A· See Remarks | Tax withholding | 16,294 | $3.01 | $49,044.94 | filing |
| 2026-07-15 | Chan Thomas (TC)· Chief Accounting Officer | Tax withholding | 2,947 | $3.01 | $8,870.47 | filing |
| 2026-07-15 | McGinnis Christopher A· See Remarks | Option exercise | 36,988 | — | — | filing |
| 2026-07-15 | Barnes Wendy Lynn· See Remarks | Option exercise | 110,963 | — | — | filing |
| 2026-07-15 | Barnes Wendy Lynn· See Remarks | Option exercise | 51,177 | — | — | filing |
| 2026-07-15 | Chan Thomas (TC)· Chief Accounting Officer | Option exercise | 5,792 | — | — | filing |
| 2026-07-15 | Barnes Wendy Lynn· See Remarks | Option exercise | 115,148 | — | — | filing |
| 2026-06-16 | Wagner Scott | Award | 73,434 | $0.00 | $0.00 | filing |
| 2026-06-16 | REY-GIRAUD AGNES | Award | 73,434 | $0.00 | $0.00 | filing |
| 2026-06-16 | Kennedy Kelly J. | Award | 73,434 | $0.00 | $0.00 | filing |
| 2026-06-16 | Hirsch Douglas Joseph | Award | 73,434 | $0.00 | $0.00 | filing |
| 2026-06-16 | Bruehlman Ronald E | Award | 73,434 | $0.00 | $0.00 | filing |
| 2026-06-16 | Bezdek Trevor | Award | 73,434 | $0.00 | $0.00 | filing |
| 2026-06-15 | Chan Thomas (TC)· Chief Accounting Officer | Tax withholding | 1,069 | $2.65 | $2,832.85 | filing |
| 2026-06-15 | Chan Thomas (TC)· Chief Accounting Officer | Tax withholding | 1,002 | $2.65 | $2,655.30 | filing |
| 2026-06-15 | Chan Thomas (TC)· Chief Accounting Officer | Option exercise | 2,100 | — | — | filing |
| 2026-06-15 | Chan Thomas (TC)· Chief Accounting Officer | Option exercise | 1,969 | — | — | filing |
| 2026-06-08 | Bezdek Trevor | Award | 110,294 | $0.00 | $0.00 | filing |
| 2026-05-27 | Hirsch Douglas Joseph | Award | 4,642 | $0.00 | $0.00 | filing |
| 2026-05-27 | Bruehlman Ronald E | Award | 4,642 | $0.00 | $0.00 | filing |
| 2026-05-15 | McGinnis Christopher A· See Remarks | Tax withholding | 19,726 | $2.49 | $49,117.74 | filing |
| 2026-05-15 | Chan Thomas (TC)· Chief Accounting Officer | Tax withholding | 1,342 | $2.49 | $3,341.58 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.